Alkermes Investigational Site

Indianapolis, Indiana 46260

1 studies enrolling now · 6 studies all time

What they study most

Bipolar I Disorder, Major Depressive Disorder, Multiple Sclerosis, OIC, Schizophrenia

Studies at this site

• Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects — Enrolling by invitation
• Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) — Completed
• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) — Completed